JY
AQST icon

Jeff Yass’s Aquestive Therapeutics AQST Stock Holding History

Jeff Yass’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Sell
949,800
-6,700
-0.7% -$28.2K ﹤0.01% 5079
2026
Q1 		$3.97M Buy
956,500
+401,600
+72% +$1.63M ﹤0.01% 4680
2025
Q4 		$3.58M Buy
554,900
+398,400
+255% +$2.48M ﹤0.01% 4568
2025
Q3 		$875K Buy
156,500
+107,700
+221% +$466K ﹤0.01% 7665
2025
Q2 		$162K Buy
48,800
+4,600
+10% +$13.2K ﹤0.01% 11441
2025
Q1 		$128K Sell
44,200
-43,500
-50% -$132K ﹤0.01% 11348
2024
Q4 		$312K Sell
87,700
-342,100
-80% -$1.58M ﹤0.01% 9754
2024
Q3 		$2.14M Buy
429,800
+220,400
+105% +$858K ﹤0.01% 5142
2024
Q2 		$544K Sell
209,400
-131,600
-39% -$440K ﹤0.01% 8061
2024
Q1 		$1.45M Buy
341,000
+228,900
+204% +$762K ﹤0.01% 6080
2023
Q4 		$226K Buy
112,100
+50,300
+81% +$88.9K ﹤0.01% 10423
2023
Q3 		$94.6K Buy
61,800
+33,900
+122% +$58.3K ﹤0.01% 10969
2023
Q2 		$46K Buy
+27,900
New +$50.5K ﹤0.01% 11370
2022
Q2 		– Sell
-61,600
Closed -$161K – 12817
2022
Q1 		$161K Sell
61,600
-45,500
-42% -$133K ﹤0.01% 11488
2021
Q4 		$417K Buy
107,100
+42,900
+67% +$215K ﹤0.01% 9655
2021
Q3 		$280K Buy
64,200
+38,000
+145% +$149K ﹤0.01% 10749
2021
Q2 		$104K Sell
26,200
-17,900
-41% -$71.5K ﹤0.01% 12075
2021
Q1 		$229K Buy
+44,100
New +$235K ﹤0.01% 11148
2020
Q3 		– Sell
-115,500
Closed -$561K – 10503
2020
Q2 		$561K Buy
+115,500
New +$532K ﹤0.01% 7130

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Jeff Yass's AQST Position: Q2 2026 in Review

Jeff Yass reduced its Aquestive Therapeutics (AQST) stake by 62% in Q2 2026, selling an estimated $880K and leaving 128,505 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #9768.

Jeff Yass first reported a position in AQST in Q4 2019 and has held it in 24 quarters since. The position peaked at $6.09M in Q3 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Jeff Yass held 128,505 shares of Aquestive Therapeutics worth $535K as of Q2 2026.
  • Jeff Yass sold 209,130 Aquestive Therapeutics shares in Q2 2026, an estimated $880K.
  • Aquestive Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9768 holding.
  • Jeff Yass first reported a position in Aquestive Therapeutics in Q4 2019 and has held it in 24 quarters since.
  • Jeff Yass's Aquestive Therapeutics position peaked at $6.09M in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.